Cargando…
Network meta-analysis on efficacy and safety of different biologics for ulcerative colitis
BACKGROUND: Therapeutic options for ulcerative colitis (UC) have increased since the introduction of biologics a few decades ago. Due to the wide range of biologics available, physicians have difficulty in selecting biologics and do not know how to balance the best drug between clinical efficacy and...
Autores principales: | Chu, Xinqiao, Biao, Yaning, Liu, Chengjiang, Zhang, Yixin, Liu, Chenxu, Ma, Ji-zheng, Guo, Yufeng, Gu, Yaru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10557260/ https://www.ncbi.nlm.nih.gov/pubmed/37803294 http://dx.doi.org/10.1186/s12876-023-02938-6 |
Ejemplares similares
-
Efficacy and safety of Qingre-Chushi therapies in active ulcerative colitis: A network meta-analysis
por: Zhang, Ling, et al.
Publicado: (2021) -
Integrated bioinformatics and network pharmacology to identify the therapeutic target and molecular mechanisms of Huangqin decoction on ulcerative Colitis
por: Wu, Yi, et al.
Publicado: (2022) -
Biologics in the management of ulcerative colitis – comparative safety and efficacy of TNF-α antagonists
por: Fausel, Rebecca, et al.
Publicado: (2015) -
Efficacy and Safety of Vitamin D Adjuvant Therapy for Ulcerative Colitis: A Meta-Analysis
por: Guo, Xinyi, et al.
Publicado: (2022) -
An indirect comparison of efficacy including histologic assessment and safety in biologic therapy in ulcerative colitis: Systemic review and network meta-analysis
por: Chae, Kyungsun, et al.
Publicado: (2023)